Eledon Pharmaceuticals, Inc. (ELDN) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2011: -$30.43M2012: -$39.90M2013: -$55.27M2014: $103.50M2015: $2.78M2016: -$2.70M2017: $19.45M2018: $14.49M2019: $9.46M2020: $190.60M2021: $164.00M2022: $23.79M2023: -$48.49M2024: $62.45M2025: $81.08M$81.08M
2011Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$81.08M+29.8%
2024$62.45M+228.8%
2023-$48.49M-303.8%
2022$23.79M-85.5%
2021$164.00M-14.0%
2020$190.60M+1913.7%
2019$9.46M-34.7%
2018$14.49M-25.5%
2017$19.45M+819.9%
2016-$2.70M-197.1%
2015$2.78M-97.3%
2014$103.50M+287.3%
2013-$55.27M-38.5%
2012-$39.90M-31.1%
2011-$30.43M